Skip to main content
Top
Published in: BMC Women's Health 1/2018

Open Access 01-12-2018 | Research article

Subclinical hypothyroidism would not lead to female sexual dysfunction in Chinese women

Authors: Han Luo, Wanjun Zhao, Hongliu Yang, Qianqian Han, Li Zeng, Huairong Tang, Jingqiang Zhu

Published in: BMC Women's Health | Issue 1/2018

Login to get access

Abstract

Background

There is dearth of research about female sexual dysfunction (FSD), especially in China, because of conservative beliefs. Previous studies indicated the relationship between subclinical hypothyroidism and anxiety and depression. However, there is dearth of research regarding the relationship between subclinical hypothyroidism and FSD in Chinses women.

Method

A hospital-based research was conducted. Female sexual function was measured by CVFSFI which includes 19 items. Participants were identified as FSD if CVFSFI ≤ 23.45. Logistics analysis was used to determine risk factor of FSD. All of them finished CVFSFI, Beck Depression Inventory (BDI) self-reporting questionnaires and had thyroid hormone tests. Based on presence and absence of subclinical hypothyroidism, participants were divided into two groups. Risk factors of FSD were identified.

Result

One thousand one hundred nineteen participants with CVFSFI score 25.8 ± 3.9 were enrolled in final analysis. Incidence of subclinical hypothyroidism and FSD in Chinese women was 15.0% and 26.5% respectively. There were no significant difference between subclinical hypothyroidism and control group in FSFI score and prevalence of FSD. Age, Depression (medium risk) was identified as risk factors for nearly all types of FSD, and Income (ranges from 40,000 to 100,000 RMB/year) as protective factor. Subclinical hypothyroidism had no significant relationship with FSD.

Conclusion

Subclinical hypothyroidism is not the risk factor for FSD in urban women of China.
Literature
1.
go back to reference ACOG Practice Bulletin No. 119. Female sexual dysfunction. Obstet Gynecol. 117:996–1007. ACOG Practice Bulletin No. 119. Female sexual dysfunction. Obstet Gynecol. 117:996–1007.
2.
go back to reference Corona G, FC W, Forti G, Lee DM, O'Connor DB, et al. Thyroid hormones and male sexual function. Int J Androl. 2012;35:668–79.CrossRefPubMed Corona G, FC W, Forti G, Lee DM, O'Connor DB, et al. Thyroid hormones and male sexual function. Int J Androl. 2012;35:668–79.CrossRefPubMed
3.
go back to reference Amidu N, Owiredu WK, Woode E, Addai-Mensah O, Quaye L, et al. Incidence of sexual dysfunction: a prospective survey in Ghanaian females. Reprod Biol Endocrinol. 2010;8:106.CrossRefPubMedPubMedCentral Amidu N, Owiredu WK, Woode E, Addai-Mensah O, Quaye L, et al. Incidence of sexual dysfunction: a prospective survey in Ghanaian females. Reprod Biol Endocrinol. 2010;8:106.CrossRefPubMedPubMedCentral
4.
go back to reference Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int J Impot Res. 2005;17:39–57.CrossRefPubMed Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int J Impot Res. 2005;17:39–57.CrossRefPubMed
5.
go back to reference McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:135–43.CrossRefPubMed McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:135–43.CrossRefPubMed
6.
go back to reference Clayton AH, Hamilton DV (2009) Female sexual dysfunction. Obstet Gynecol Clin N Am 36: 861–876, xi. Clayton AH, Hamilton DV (2009) Female sexual dysfunction. Obstet Gynecol Clin N Am 36: 861–876, xi.
7.
go back to reference Ma J, Pan L, Lei Y, Zhang A, Kan Y. Prevalence of female sexual dysfunction in urban chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary study. J Sex Med. 2014;11:909–19.CrossRefPubMed Ma J, Pan L, Lei Y, Zhang A, Kan Y. Prevalence of female sexual dysfunction in urban chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary study. J Sex Med. 2014;11:909–19.CrossRefPubMed
8.
go back to reference Salonia A, Munarriz RM, Naspro R, Nappi RE, Briganti A, et al. Women's sexual dysfunction: a pathophysiological review. BJU Int. 2004;93:1156–64.CrossRefPubMed Salonia A, Munarriz RM, Naspro R, Nappi RE, Briganti A, et al. Women's sexual dysfunction: a pathophysiological review. BJU Int. 2004;93:1156–64.CrossRefPubMed
9.
go back to reference Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, et al. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int. 2004;72:52–7.CrossRefPubMed Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, et al. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int. 2004;72:52–7.CrossRefPubMed
10.
go back to reference Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–611.CrossRefPubMed Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–611.CrossRefPubMed
11.
go back to reference Balercia G, Boscaro M, Lombardo F, Carosa E, Lenzi A, et al. Sexual symptoms in endocrine diseases: psychosomatic perspectives. Psychother Psychosom. 2007;76:134–40.CrossRefPubMed Balercia G, Boscaro M, Lombardo F, Carosa E, Lenzi A, et al. Sexual symptoms in endocrine diseases: psychosomatic perspectives. Psychother Psychosom. 2007;76:134–40.CrossRefPubMed
12.
go back to reference Pasquali D, Maiorino MI, Renzullo A, Bellastella G, Accardo G, et al. Female sexual dysfunction in women with thyroid disorders. J Endocrinol Investig. 2013;36:729–33.CrossRef Pasquali D, Maiorino MI, Renzullo A, Bellastella G, Accardo G, et al. Female sexual dysfunction in women with thyroid disorders. J Endocrinol Investig. 2013;36:729–33.CrossRef
13.
go back to reference Prabhakar VK, Davis JR. Hyperprolactinaemia. Best Pract Res Clin Obstet Gynaecol. 2008;22:341–53.CrossRefPubMed Prabhakar VK, Davis JR. Hyperprolactinaemia. Best Pract Res Clin Obstet Gynaecol. 2008;22:341–53.CrossRefPubMed
14.
go back to reference Brenta G, Schnitman M, Gurfinkiel M, Damilano S, Pierini A, et al. Variations of sex hormone-binding globulin in thyroid dysfunction. Thyroid. 1999;9:273–7.CrossRefPubMed Brenta G, Schnitman M, Gurfinkiel M, Damilano S, Pierini A, et al. Variations of sex hormone-binding globulin in thyroid dysfunction. Thyroid. 1999;9:273–7.CrossRefPubMed
15.
go back to reference Traish AM, Kim N, Min K, Munarriz R, Goldstein I. Role of androgens in female genital sexual arousal: receptor expression, structure, and function. Fertil Steril. 2002;77(Suppl 4):S11–8.CrossRefPubMed Traish AM, Kim N, Min K, Munarriz R, Goldstein I. Role of androgens in female genital sexual arousal: receptor expression, structure, and function. Fertil Steril. 2002;77(Suppl 4):S11–8.CrossRefPubMed
16.
go back to reference Atis G, Dalkilinc A, Altuntas Y, Atis A, Caskurlu T, et al. Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism. J Sex Med. 2010;7:2583–90.CrossRefPubMed Atis G, Dalkilinc A, Altuntas Y, Atis A, Caskurlu T, et al. Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism. J Sex Med. 2010;7:2583–90.CrossRefPubMed
17.
go back to reference Hong H, Lee HJ, Kim SM, Jeon MJ, Shin DW, et al. Subclinical hypothyroidism is not a risk factor for female sexual dysfunction in Korean middle-aged women. Thyroid. 2015;25:784–8.CrossRefPubMed Hong H, Lee HJ, Kim SM, Jeon MJ, Shin DW, et al. Subclinical hypothyroidism is not a risk factor for female sexual dysfunction in Korean middle-aged women. Thyroid. 2015;25:784–8.CrossRefPubMed
18.
go back to reference Luo H, Yang H, Zhao W, Han Q, Zeng L, et al. Elevated free triiodothyronine may lead to female sexual dysfunction in Chinese urban women: a hospital-based survey. Sci Rep. 2017;7:1216.CrossRefPubMedPubMedCentral Luo H, Yang H, Zhao W, Han Q, Zeng L, et al. Elevated free triiodothyronine may lead to female sexual dysfunction in Chinese urban women: a hospital-based survey. Sci Rep. 2017;7:1216.CrossRefPubMedPubMedCentral
19.
go back to reference Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13:391–7.CrossRefPubMed Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13:391–7.CrossRefPubMed
20.
go back to reference Sun X, Li C, Jin L, Fan Y, Wang D. Development and validation of Chinese version of female sexual function index in a Chinese population-a pilot study. J Sex Med. 2011;8:1101–11.CrossRefPubMed Sun X, Li C, Jin L, Fan Y, Wang D. Development and validation of Chinese version of female sexual function index in a Chinese population-a pilot study. J Sex Med. 2011;8:1101–11.CrossRefPubMed
21.
go back to reference Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526–34.CrossRefPubMed Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526–34.CrossRefPubMed
22.
go back to reference Kanaya AM, Harris F, Volpato S, Perez-Stable EJ, Harris T, et al. Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Arch Intern Med. 2002;162:773–9.CrossRefPubMed Kanaya AM, Harris F, Volpato S, Perez-Stable EJ, Harris T, et al. Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Arch Intern Med. 2002;162:773–9.CrossRefPubMed
23.
go back to reference Shan Z, Chen L, Lian X, Liu C, Shi B, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid. 2016;26:1125–30.CrossRefPubMed Shan Z, Chen L, Lian X, Liu C, Shi B, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid. 2016;26:1125–30.CrossRefPubMed
24.
go back to reference Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.CrossRefPubMed Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.CrossRefPubMed
25.
go back to reference Goshtasebi A, Vahdaninia M, Rahimi Foroshani A. Prevalence and potential risk factors of female sexual difficulties: an urban Iranian population-based study. J Sex Med. 2009;6:2988–96.CrossRefPubMed Goshtasebi A, Vahdaninia M, Rahimi Foroshani A. Prevalence and potential risk factors of female sexual difficulties: an urban Iranian population-based study. J Sex Med. 2009;6:2988–96.CrossRefPubMed
26.
go back to reference Ibrahim ZM, Ahmed MR, Sayed Ahmed WA. Prevalence and risk factors for female sexual dysfunction among Egyptian women. Arch Gynecol Obstet. 2013;287:1173–80.CrossRefPubMed Ibrahim ZM, Ahmed MR, Sayed Ahmed WA. Prevalence and risk factors for female sexual dysfunction among Egyptian women. Arch Gynecol Obstet. 2013;287:1173–80.CrossRefPubMed
27.
go back to reference Echeverry MC, Arango A, Castro B, Raigosa G. Study of the prevalence of female sexual dysfunction in sexually active women 18 to 40 years of age in Medellin, Colombia. J Sex Med. 2010;7:2663–9.CrossRefPubMed Echeverry MC, Arango A, Castro B, Raigosa G. Study of the prevalence of female sexual dysfunction in sexually active women 18 to 40 years of age in Medellin, Colombia. J Sex Med. 2010;7:2663–9.CrossRefPubMed
28.
go back to reference Sidi H, Puteh SE, Abdullah N, Midin M. The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women. J Sex Med. 2007;4:311–21.CrossRefPubMed Sidi H, Puteh SE, Abdullah N, Midin M. The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women. J Sex Med. 2007;4:311–21.CrossRefPubMed
29.
go back to reference Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18:382–95.CrossRefPubMed Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18:382–95.CrossRefPubMed
30.
go back to reference Oniz A, Keskinoglu P, Bezircioglu I. The prevalence and causes of sexual problems among premenopausal Turkish women. J Sex Med. 2007;4:1575–81.CrossRefPubMed Oniz A, Keskinoglu P, Bezircioglu I. The prevalence and causes of sexual problems among premenopausal Turkish women. J Sex Med. 2007;4:1575–81.CrossRefPubMed
31.
go back to reference Kucukdurmaz F, Efe E, Malkoc O, Kolus E, Amasyali AS, et al. Prevalence and correlates of female sexual dysfunction among Turkish pregnant women. Turk J Urol. 2016;42:178–83.CrossRefPubMedPubMedCentral Kucukdurmaz F, Efe E, Malkoc O, Kolus E, Amasyali AS, et al. Prevalence and correlates of female sexual dysfunction among Turkish pregnant women. Turk J Urol. 2016;42:178–83.CrossRefPubMedPubMedCentral
32.
go back to reference Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489–99.CrossRefPubMed Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489–99.CrossRefPubMed
33.
go back to reference Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365–74.CrossRefPubMedPubMedCentral Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365–74.CrossRefPubMedPubMedCentral
34.
go back to reference Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126:1040–9.CrossRefPubMed Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126:1040–9.CrossRefPubMed
35.
go back to reference Hyland KA, Arnold AM, Lee JS, Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2013;98:533–40.CrossRefPubMed Hyland KA, Arnold AM, Lee JS, Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2013;98:533–40.CrossRefPubMed
36.
go back to reference Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The cardiovascular health study. J Am Coll Cardiol. 2008;52:1152–9.CrossRefPubMedPubMedCentral Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The cardiovascular health study. J Am Coll Cardiol. 2008;52:1152–9.CrossRefPubMedPubMedCentral
37.
go back to reference Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel thyroid study). J Clin Endocrinol Metab. 2001;86:4860–6.CrossRefPubMed Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel thyroid study). J Clin Endocrinol Metab. 2001;86:4860–6.CrossRefPubMed
Metadata
Title
Subclinical hypothyroidism would not lead to female sexual dysfunction in Chinese women
Authors
Han Luo
Wanjun Zhao
Hongliu Yang
Qianqian Han
Li Zeng
Huairong Tang
Jingqiang Zhu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2018
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-017-0465-0

Other articles of this Issue 1/2018

BMC Women's Health 1/2018 Go to the issue